Raynaud’s Phenomenon as a Manifestation of Vasculitis C – ANCA: Case Report and Literature Review

Main Article Content

Ana Livia Domínguez Rodríguez
Perla Karina Hernández de Lira
Andrea Carolina Torres Ruiz
Elizabeth Torres Ruiz

Abstract

Raynaud's phenomenon is a vasospastic condition affecting capillaries in the distal region of the extremities. It is divided into primary and secondary and 80-90% of patients are associated with primary or idiopathic disease, while 10-20% are secondary, with multiple etiologies including connective tissue, vascular, hematologic, and endocrinopathic diseases.


Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) correspond to a group of necrotizing vasculitides of medium (0.2 to 2.0 mm in diameter) and small blood vessels (arterioles, capillaries, postcapillary venules). Clinically, it is characterized by multisystem involvement, with upper and lower respiratory tract and renal damage standing out for their frequency. The least frequent manifestations are cutaneous, with digital ischemia and gangrene occurring in less than 1% of cases.


The diagnosis is based on a detailed clinical history and physical examination in addition to complementary studies including a complete metabolic panel, muscle enzymes, viral panel, thyroid profile and a rheumatologic panel to assess secondary causes of Raynaud's phenomenon.


Calcium antagonists are considered the first-line treatment in both etiologies, and phosphodiesterase-5 inhibitors are another alternative.


This article presents a case of a patient with Raynaud's phenomenon as an initial clinical manifestation and later presentation of C-ANCA vasculitis.

Article Details

How to Cite
Domínguez Rodríguez, A. L., Hernández de Lira, P. K., Torres Ruiz, A. C., & Torres Ruiz, E. (2023). Raynaud’s Phenomenon as a Manifestation of Vasculitis C – ANCA: Case Report and Literature Review. International Journal of Medical Science and Clinical Research Studies, 3(12), 3235–3239. https://doi.org/10.47191/ijmscrs/v3-i12-54
Section
Articles

References

I. Vulasala, S. S., Ahmed, S., Onteddu, N. K., Mannem, M., & Mukkera, S. (2021). Raynaud's Secondary to Granulomatosis With Polyangiitis. Cureus, 13(8), e17551. https://doi.org/10.7759/cureus.17551

II. Fardoun, M. M., Nassif, J., Issa, K., Baydoun, E., & Eid, A. H. (2016). Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms. Frontiers in pharmacology, 7, 438. https://doi.org/10.3389/fphar.2016.00438

III. Choi, E., & Henkin, S. (2021). Raynaud's phenomenon and related vasospastic disorders. Vascular medicine (London, England), 26(1), 56–70. https://doi.org/10.1177/1358863X20983455

IV. Temprano KK. (2016) A Review of Raynaud's Disease. Missouri Medicine. Mar-Apr;113(2):123-6. PMID: 27311222; PMCID: PMC6139949.

V. Haque, A., & Hughes, M. (2020). Raynaud's phenomenon. Clinical medicine (London, England), 20(6), 580–587. https://doi.org/10.7861/clinmed.2020-0754

VI. Micheletti, R. G., Chiesa Fuxench, Z., Craven, A., Watts, R. A., Luqmani, R. A., & Merkel, P. A. (2020). Cutaneous manifestations

VII. of anti‐neutrophil cytoplasmic antibody‐associated vasculitis. Arthritis & Rheumatology. (Hoboken, N.J.), 72(10), 1741–1747. https://doi.org/10.1002/art.41310

VIII. Pauling, J. D., Hughes, M., & Pope, J. E. (2019). Raynaud's phenomenon-an update on diagnosis, classification and management. Clinical rheumatology, 38(12), 3317–3330. https://doi.org/10.1007/s10067-019-04745-5

IX. Souza, E. J. do R. e, & Kayser, C. (2015). Nailfold capillaroscopy: relevance to the practice of rheumatology. Revista Brasileira de Reumatología (English Edition), 55(3), 264–271. https://doi.org/10.1016/j.rbre.2014.09.005

X. Shapiro, S. C., & Wigley, F. M. (2017). Treating Raynaud phenomenon: Beyond staying warm. Cleveland Clinic journal of medicine, 84(10), 797–804. https://doi.org/10.3949/ccjm.84a.17025

XI. Shenoy PD, Kumar S, Jha LK, Choudhary SK, Singh U, Misra R, Agarwal V. (2010). Efficacy of tadalafil in secondary Raynaud’s phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial, Rheumatology, Volume 49 Issue 12. 2420–2428, https://doi.org/10.1093/rheumatology/keq291

XII. Lutalo, P. M., & D'Cruz, D. P. (2014). Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis). Journal of autoimmunity, 48-49, 94–98. https://doi.org/10.1016/j.jaut.2014.01.028

XIII. Allard-Chamard, H., & Liang, P. (2019). Antineutrophil Cytoplasmic Antibodies Testing and Interpretation. Clinics in Laboratory Medicine, 39(4), 539–552. https://doi.org/10.1016/j.cll.2019.07.003

XIV. Lau, R. A., Bains, R., Suraweera, D., Ma, J., Heinze, E. R., Wong, A. L., & Clements, P. J. (2017). A Rare Case of Digital Ischemia and Gangrene in ANCA-Associated Vasculitis with Review of the Literature. Case reports in rheumatology, 2017, 2421760. https://doi.org/10.1155/2017/2421760

XV. Kubaisi, B., Abu Samra, K., & Foster, C. S. (2016). Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations. Intractable & rare diseases research, 5(2), 61–69. https://doi.org/10.5582/irdr.2016.01014.

XVI. Kitching, A. R., Anders, H. J., Basu, N., Brouwer, E., Gordon, J., Jayne, D. R., Kullman, J., Lyons, P. A., Merkel, P. A., Savage, C. O. S., Specks, U., & Kain, R. (2020). ANCA-associated vasculitis. Nature reviews. Disease primers, 6(1), 71. https://doi.org/10.1038/s41572-020-0204-y

XVII. Ladrón de Guevara, David, Cerda, Felipe, Ángela Carreño, María, Piottante, Antonio, & Bitar, Patricia. (2019). Actualización en el estudio de Granulomatosis con poliangeitis (Granulomatosis de Wegener). Revista chilena de radiología, 25(1), 26-34. https://dx.doi.org/10.4067/S0717-93082019000100026

XVIII. Almaani, S., Fussner, L. A., Brodsky, S., Meara, A. S., & Jayne, D. (2021). ANCA-Associated Vasculitis: An Update. Journal of clinical medicine, 10(7), 1446. https://doi.org/10.3390/jcm10071446

XIX. Lakhani, D. A., Balar, A. B., Adelanwa, A., Gross, A., Mohamed, R., Smith, K. T., & Kim, C. (2021). Granulomatosis with polyangiitis: A case report and brief review of literature. Radiology case reports, 16(11), 3445–3450. https://doi.org/10.1016/j.radcr.2021.08.028.

XX. Devgire, V., & Hughes, M. (2019). Raynaud's phenomenon. British journal of hospital medicine (London, England : 2005), 80(11), 658–664. https://doi.org/10.12968/hmed.2019.80.11.658

XXI. Ross, C., Makhzoum, J. P., & Pagnoux, C. (2022). Updates in ANCA-associated vasculitis. European journal of rheumatology, 9(3), 153–166. https://doi.org/10.5152/eujrheum.2022.20248.

Most read articles by the same author(s)